Baron Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Baron Wealth Management's BMY Position: Q2 2025 in Review
Baron Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,347 shares — an estimated $265K sold.
Baron Wealth Management first reported a position in BMY in Q3 2024 and held it in 3 quarters. The position peaked at $265K in Q1 2025. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Baron Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- Baron Wealth Management sold 4,347 Bristol-Myers Squibb shares in Q2 2025, an estimated $265K.
- Baron Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 3 quarters.
- Baron Wealth Management's Bristol-Myers Squibb position peaked at $265K in Q1 2025.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Baron Wealth Management's 13F filing for Q2 2025, filed 9 Jul 2025.